// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Worm M - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Epinephrine

Wheeler K - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Gastric antral vascular ectasia

N/A

Van De Loo AJ - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

IL-4

Albers F - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Mepolizumab

Kayode OS - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

Salbutamol

Azmi S - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Anaphylaxis

Cetirizine Dihydrochloride

Elkhalifa S - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Lyons SA - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Tadros S - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hypogammaglobulinaemia

N/A

Birdi G - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Atopic Dermatitis

N/A

Sharma V - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

O'Quinn S - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Kennard L - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Minale P - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

inulin Intravenous

Denton S - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Anaphylaxis

N/A

Warner A - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Newman K - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Makatsori M - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Alvares I - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Astafieva N - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A